TwitterLinkedinSkypeRssEmail
+1.970.776.4355
BlueIron IP
  • About
  • IP-Backed Loans
  • Blog
  • All FAQs
    • Patent Loans
    • Patent Law FAQ
  • Contact
  • Schedule a Call

Is it necessary to specify dosage or method of use in a patent application?

By russ.krajec@blueironip.com | September 30, 2024

Generally, it is not necessary to specify the dosage or method of use in a patent application if: It is known to one skilled in the art that such information could be obtained without undue experimentation One skilled in the art, based on knowledge of compounds with similar physiological or biological activity, could discern an…

Read More

What information is required to demonstrate that a patent claims the approved product?

By russ.krajec@blueironip.com | September 29, 2024

To demonstrate that a patent claims the approved product in a patent term extension application, 37 CFR 1.740(a)(9) requires the following: “The application need only explain how one product claim of the patent claims the approved product, if there is a claim to the product. In addition, the application need only explain how one method…

Read More

Search

Categories

Recent Posts

  • Stolen Valor: How Sleazy Patent Attorneys Abuse Inventorship
  • Four Horsemen of the Investor Apocalypse
  • AI-Assisted Patent Search Tools Exacerbate Inventor Biases
  • Your Patent Attorney Is NOT Giving Business Advice
  • Contempt from Crowdfunded Equity
  • Entrepreneurs and Imposter Syndrome
  • AI Startups: Protect Everything EXCEPT the Patent
  • Blog
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Media Kit
BlueIron IP | 1635 Foxtrail Drive, Ste 321 | Loveland, Colorado 80538 | USA